Subjective tympanophonia. The current concepts of therapy

Close metadata

Recommended articles:

Cochleovestibular manifestations in coronavirus infection. Russian Bulletin of Otorhinolaryngology. 2024;(3):18-23

Tinnitus features and masking in patients with normal hearing and with high frequency hearing loss. Russian Bulletin of Otorhinolaryngology. 2024;(5):4-9

Clinical case of unilateral tinnitus and pathology of the main vessels of the neck. Russian Bulletin of Otorhinolaryngology. 2025;(2):79-82

The authors overview the current concepts of the management of the patients complaining of subjective tympanophonia with special reference to the medicamental and non-medicamental treatment of this condition and rehabilitation. Bearing in mind a great variety of approaches to addressing this problem, only the most important, widely applied, and clinically verified methods for this purpose are considered.

Keywords:

tinnitus

subjective tympanophonia

treatment modalities for the management of subjective tympanophonia

Authors:

Gunenkov A.V.

Kafedra otorinolaringologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Kosiakov S.Ia.

Kafedra otorinolaringologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

List of references:

Jastreboff P.J. Phantom auditory perception (tinnitus): mechanisms of generation and perception. J Neurosci Res 1990; 8: 4: 221-254.
Jastreboff P.J., Hazell J.W. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol 1993; 27: 1: 7-17.
Eggermont J.J. On the pathophysiology of tinnitus: a review and a peripheral model. Hear Res 1990; 48: 111-124.
Zenner H.P., Ernst A. Cochlear-motor, transduction and signal-transfer tinnitus: models for three types of cochlear tinnitus. Eur Arch Otorhinolaryngol 1993; 249: 447-454.
Lanting C.P., De Kleine E., Bartels H., Van Dijk P. Functional imaging of unilateral tinnitus using fMRI. Acta Otolaryngol 2008; 128: 415-421.
Johnson R., Brummett R., Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 1993; 119: 842-845.
Kay N.J. Oral chemotherapy in tinnitus. Br J Audiol 1981; 15: 2: 123-124.
Szczepaniak W.S., Moller A.R. Effects of baclofen, clonazepam and diazepam on tone exposure induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. Hearing Research 1996; 97: 46-53.
Mihail R.C., Crowley J.M., Walden B.E., Fishburne J., Reinwall J.E., Zajtchuk J.T. The tricyclic trimipramine in the treatment of subjective tinnitus. Ann Otol Rhinol Laryngol 1988; 97: 2 Pt 1: 120.
Katon W., Sullivan M., Russo J., Dobie R., Sakai C. Depressive symptoms and measures of disability: A prospective study. J Affect Disord 1993; 27: 4: 245.
Azevedo A.A., Figuerido R.R. Tinnitus treatment with acamprosate: double-blind study. Braz J Otorhinolaryngol 2005; 71: 618-623.
Figueiredo R., Langguth B., Mello de Oliveira P., Aparecida de Azevedo A. Tinnitus treatment with memantine. Otolaryngol Head Neck Surg 2008; 138: 4: 492.
Domeisen H., Hotz M.A., Häusler R. Caroverine in tinnitus treatment. Acta Oto-Laryngol 1998; 118: 4: 606.
Van de Heyning, De Ridder D. Efficacy and safety of AM101 in the treatment of acute inner ear tinnitus - a double blind, randomized, placebo controlled phase II study In Proceedings of Sixth international conference on Tinnitus, Brugge 2012; 19.
Guitton M., Caston J., Ruel J., Johnson R.M., Pujol R., Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003; 23: 9: 3944.
Wenzel G., Warnecke A., Stöver T., Lenarz T. Effects of gacyclidine extracochlear perfusion on tinnitus in humans and intracochlear perfusion on ABR thresholds in guinea pigs. (http://www.aurismedical.com/p/therapies/am_101.php).
Martin F.W., Colman B.H. Tinnitus: A double-blind crossover controlled trial to evaluate the use of lignocaine. Clin Otolaryngol 1980; 5: 1: 3.
Sanchez T., Balbani A.P., Bittar R.S., Bento R.F., Câmara J. Lidocaine test in patients with tinnitus: Rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 1999; 26: 4: 411.
Duckert L.G., Rees T.S. Treatment of tinnitus with intravenous lidocaine: A double-blind randomized trial. Otolaryngol Head Neck Surg 1983; 91: 5: 550.
Bakhshae M., Ghasemi M., Azarpazhooh M., Khadivi E., Rezaei S., Shakeri M., Tale M. Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. Eur Arch Otorhinolaryngol 2008; 265: 525-530.
Bauer C.A., Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006; 116: 675-681.
Levine R.A. Typewriter tinnitus: A carbamazepine-responsive syndrome related to auditory nerve vascular compression. ORL - J Otorhinolaryngol Relat Spec 2006; 68: 1: 43.
Mardini M.K. Ear-clicking «tinnitus" responding to carbamazepine. New Engl J Med 1987; 317: 24: 1542.
Davies E., Knox E., Donaldson I. The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus. Br J Audiol 1994; 28: 3: 125-129.
Holstein N. Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials. Fortschr Med Orig 2001; 118: 4: 157-164.
Morgenstern C., Biermann E. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther 2002; 40: 5: 188.
Rejali D., Sivakumar A., Balaji N. Ginkgo biloba does not benefit patients with tinnitus: A randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clin Otolaryngol Allied Sci 2004; 29: 3: 226.
Salvi R., Lobarinas E., Sun W. Pharmacological treatments for tinnitus: new and old. Drugs Future 2009; 34: 5: 381-400.
Hall D., Láinez M.J., Newman C.W., Sanchez T.G., Egler M., Tennigkeit F., Koch M., Langguth B. Treatment options for subjective tinnitus: Self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Serv Res 2011; 11: 302.
Langguth B., Elgoyhen A.B. Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs 2009; 14: 4: 687-702.
Van de Heyning P., Vermeire K., Diebl M., Nopp P., Anderson I., De Ridder D. Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol 2008; 117: 9: 645-652.
Yonehara E., Mezzalira R., Porto P.R., Bianchini W.A., Calonga L., Curi S.B., Stoler G. Can cochlear implants decrease tinnitus? Int Tinnitus J 2006; 12: 2: 172-174.
Langguth B., Hajak G., Kleinjung T., Pridmore S., Sand P., Eichhammer P. Repetitive transcranial magnetic stimulation and chronic tinnitus. Acta Otolaryngol Suppl 2006; 556: 102-105.
Tauber S., Schorn K., Beyer W., Baumgartner R. Transmeatal cochlear laser (TCL) treatment of cochlear dysfunction: a feasibility study for chronictinnitus. Lasers Med Sci 2003; 18: 3: 154-161.
Jastreboff P.J. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990; 8: 4: 221-254.
Gudex C., Skellgaard P.H., West T., Sørensen J. Effectiveness of a tinnitus management programme: a 2-year follow-up study. BMC Ear Nose Throat Disord 2009; 9: 6.
Arnold R., Goebel G., Kahl M. Multidisciplinary assessment and treatment of tinnitus: a follow up study. In Proceedings of Sixth international conference on Tinnitus, Brugge 2012; 52.
Searchfield G., Kaur M., Martin W.H. Hearing aids as an adjunct to counseling: tinnitus patients who choose amplification do better than those that don't. Int J Audiol 2010; 49: 8: 574-579.
Herraiz C., Hernandez F.J., Plaza G., de los Santos G. Long-term clinical trial of tinnitus retraining therapy. Otolaryngol Head Neck Surg 2005; 133: 5: 774-779.

Close metadata